New York's individual-market carriers filed for an average 13% rate increase for 2026; the Department of Financial Services approved an average of 7.1%, a 47.4% cut to the requested increase (DFS, August 2025). Small-group requests fell 45.8%.
DFS credits the two decisions with $959 million in combined savings. The mechanism behind that number is prior-approval rate review: a regulator's actuarial staff overriding a carrier's filed trend and margin assumptions before a policy is ever sold.
Key Takeaways
- $148.2 million of individual-market and $810.8 million of small-group savings, covering roughly 930,000 New Yorkers across the two markets.
- Requests ranged from 1% to 38%, a 37-point spread among carriers competing in the same risk pool, cut by a near-uniform 45 to 47 percent in both markets.
- Profit provisions were held to 1.0% across the board, and New York's 82% MLR floor caps combined administrative and profit retention at roughly 18% of the reduced premium.
- Medical cost trend runs at a 10% median for the coming plan year. An approved rate built on a materially lower trend does not remove the claims cost; it moves who absorbs it.
The Filed-to-Approved Spread
DFS pegged individual-market savings at $148.2 million and small-group savings at $810.8 million, covering roughly 930,000 New Yorkers in the two markets. Individual carriers had asked for increases ranging from 1% at Emblem Health to 38% at Independent Health, and the department held insurers' profit provisions to 1.0% across the board.
| Metric | Individual Market | Small-Group Market |
|---|---|---|
| Average requested increase | 13% | Not separately disclosed by DFS |
| Reduction applied to requests | 47.4% | 45.8% |
| Approved average increase | 7.1% | Not separately disclosed by DFS |
| Claimed consumer savings | $148.2 million | $810.8 million |
| Enrollees affected (combined) | ~930,000 | |
The width of the spread is itself informative. A 37-point range in what carriers believed their own morbidity and trend data supported implies either genuinely divergent underlying experience or genuinely divergent actuarial philosophy about how much margin a filing should carry into an uncertain year.
DFS applied a roughly 45-to-47-percent reduction across both markets rather than a carrier-specific adjustment matched to each filing's stated justification. A near-halving of the requested increase, applied across markets with different risk pools and morbidity profiles, is not the outcome an independent review of each carrier's own data would typically produce unless every filing shared a common, correctable error.
The department's framing is cost-driven: "the rising cost of medical care, including in-patient hospital stays as well as rapid increases in drug prices, continues to be the main driver of health insurance premium increases," DFS said, while asserting that the filed rates went beyond what that cost trend justified.
What the Regulator Rewrites, and What the Reserve Has to Follow
New York has operated under a prior-approval statute since 2010, authorizing DFS to "disapprove or modify an insurer's request for a premium rate increase if it is unreasonable, excessive, inadequate or unfairly discriminatory" (DFS Rate Review FAQ). That reaches into the filing before a single premium is collected and changes the inputs the carrier's own actuary selected: the medical trend assumption, the utilization projection, the administrative expense load and the underwriting margin.
Landing on 7.1% against a filed 13% is not shaving basis points off an expense load. It asserts that the filing actuary's central trend estimate was materially too high, market-wide, across every carrier's book. Aggregate medical cost trend for the coming plan year runs at a 10% median (Peterson-KFF Health System Tracker), which does not obviously support a trend assumption 45% below what carriers filed.
The gap does not vanish; it changes hands. If the approved rate runs below the cost curve, it surfaces as adverse loss-ratio development against the priced-for margin, as erosion of statutory surplus built up in prior years, or as a wider filed-versus-approved gap the following year while carriers try to recoup the shortfall. Guaranteed issue and guaranteed renewability keep the carrier writing the business throughout.
From the moment of approval, the reserving actuary works from the approved number. An appointed actuary certifying year-end reserves for a New York individual or small-group book has to reflect the approved rate's adequacy against emerging claims experience, not the filing's original indication. Reserving as though the filed 13% trend were still operative would misstate the liability the carrier actually holds. That is not the position in a file-and-use state, where rates take effect on filing and any challenge comes afterward; Illinois moved toward New York's model for plan years beginning January 1, 2026 under P.A. 103-0106 (Illinois Administrative Code Title 50).
The MLR Floor Removes the Cushion
Federal law sets an 80% MLR floor for individual and small-group plans and 85% for large group (CMS MLR Final Rule), and New York's own standard runs two points higher, requiring individual and small-group carriers to direct at least 82% of premium to claims and quality improvement. Insurers nationally expect to issue just over $759 million in rebates in 2026, calculated on the rolling three-year average of 2023 through 2025 experience (KFF).
A rate cut of this size squeezes that calculation from both directions. If claims trend runs closer to the carrier's original filing than to the approved assumption, claims consume a larger share of the now-smaller approved premium, pushing realized MLR up and administrative margin down. If the cut rate proves adequate and claims come in as DFS projected, combined administrative and profit retention is still capped at roughly 18% of premium under the 82% floor.
Either outcome leaves less margin for error than the carrier's own filing built in. A state that cuts the rate has also compressed the cushion that normally buffers year-to-year trend volatility, and that cushion is precisely what a carrier draws on in a bad trend year.
The recalibration problem compounds it. DFS's public materials do not disclose whether the reduction was driven primarily by a trend adjustment, a margin cut or an administrative expense disallowance. A carrier cannot rebuild next year's filing methodology against a decision it cannot decompose.
Further Reading
- ACA 2027 Rate Filings Land With 22% to 30% Premium Hikes Across Eight States – How carrier-level morbidity adjustments and post-subsidy adverse selection are showing up in 2027 filings submitted while the replacement rule landscape and state review outcomes remain unsettled.
- Illinois's New Prior-Review Rate Law Tests Actuarial Credibility Standards – A parallel look at a state moving from file-and-use toward prior-approval authority, and what that shift does to the credibility standard a filing actuary must meet.
- ACA MLR Rebates Hit $759 Million as the Margin Floor Tightens – The mechanics of the medical loss ratio rebate calculation and why insurers are running closer to the floor across commercial lines.
- KFF's 2027 Marketplace Filings Show a 15% Median Ask After the Subsidy Cliff – The broader 2027 marketplace rate-filing trend against which any single state's prior-approval outcome should be benchmarked.
- Segal's 2027 Trend Study Puts Rx Growth at 9.9% and Renewal Pricing at 11.5% – Independent trend benchmarks actuaries can use to stress-test whether a regulator's approved trend assumption is defensible against market data.
- Vermont's 2027 Rate Cut Comes With a Reference-Pricing Order – A rate cut paired with an order that changes the unit-cost methodology behind every future filing, not just this year's number.
- Health Insurance Hub – actuary.info's full coverage of health actuarial topics, including ACA market dynamics, employer benefits, and regulatory developments.
- California's Intervenor Overhaul Rewrites Who Pays to Fight a Rate Filing – A property/casualty prior-approval regime where the filed-versus-approved gap runs through an intervenor fee mechanism rather than DFS staff review alone.
Sources
- NY DFS: DFS Approves 2026 Health Insurance Rates, Saving Consumers and Small Businesses an Estimated $959 Million (August 2025)
- NY DFS: FAQ, Health Insurance Rate Review and Prior Approval
- NY DFS: FAQ, Prior Approval
- NY DFS Portal: Summary of 2026 Requested Rate Actions, Individual and Small Group
- CMS: Medical Loss Ratio, Getting Your Money's Worth on Health Insurance
- KFF: 2026 Medical Loss Ratio Rebates
- Peterson-KFF Health System Tracker: How Much and Why ACA Marketplace Premiums Are Going Up in 2027
- Illinois Administrative Code, Title 50, Part 2026: Health Insurance Rate Review
- NAIC: Product Filing Review Handbook (2024)